A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/50 (2006.01) A61K 31/14 (2006.01) A61K 31/42 (2006.01) A61K 31/445 (2006.01) A61K 31/465 (2006.01) A61K 31/495 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2324237
The present invention relates to a combination of a nicotinic agonist and an inverse agonist of the GABAA .alpha.5 receptor subtype, and the use of the combination in treating neurodegenerative conditions such as Alzheimer's Disease.
L'invention porte sur une combinaison d'un agoniste de la nicotine et d'un agoniste inverse du sous type .alpha.¿5? du récepteur GABA¿A? et sur l'utilisation de ladite combinaison pour le traitement de troubles de neurodégénerescence tels que la maladie d'Alzheimer.
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Combination of a gaba-a alpha 5 inverse agonist and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of a gaba-a alpha 5 inverse agonist and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a gaba-a alpha 5 inverse agonist and a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1547448